Ultragenyx Pharmaceutical | RARE - DÍVIDA





DÍVIDA Alterar Data
Acadia Pharmaceuticals USD 54.81M 1.48M 2025-09
Agios Pharmaceuticals USD 44.52M 4.24M 2025-09
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Immunic USD 0 0 2024-06
Insmed USD 727.89M 163.33M 2025-12
Ionis Pharmaceuticals USD 2.33B 1.1B 2025-12
Karyopharm Therapeutics USD 264.09M 39.31M 2024-09
Kyowa Hakko Kirin JPY 28.75B 5.04B 2024-12
MacroGenics USD 37.01M 238K 2025-09
Moderna USD 734M 7M 2025-09
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
PTC Therapeutics USD 286.32M 306K 2025-09
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Ultragenyx Pharmaceutical USD 33.83M 2.46M 2025-09
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09
Xoma USD 120.79M 3.27M 2024-06